BRIEF published on 01/10/2025 at 13:05, 1 year 6 months ago Lumira Ventures Promotes Suman Rao to Principal Healthcare Innovation Venture Capital Lumira Ventures Suman Rao Principal Promotion
BRIEF published on 01/10/2025 at 13:05, 1 year 6 months ago Lumira Ventures promeut Suman Rao au poste de directeur Capital-risque Lumira Ventures Innovation Dans Le Domaine De La Santé Suman Rao Promotion Principale
PRESS RELEASE published on 01/10/2025 at 13:00, 1 year 6 months ago Lumira Ventures Announces Promotion of Suman Rao to Principal Lumira Ventures promotes Suman Rao, Ph.D., to Principal, recognizing her contributions to healthcare innovation. Read more about her journey and achievements Healthcare Innovation Venture Capital Lumira Ventures Biomedical Suman Rao
BRIEF published on 06/26/2024 at 13:05, 2 years ago Lumira Ventures Promotes Nikhil Thatte to Partner Promotion Life Sciences Lumira Ventures Healthcare Investment Nikhil Thatte
BRIEF published on 06/26/2024 at 13:05, 2 years ago Lumira Ventures promeut Nikhil Thatte comme partenaire Promotion Lumira Ventures Investissement Dans La Santé Sciences De La Vie Nikhil Thatte
PRESS RELEASE published on 06/26/2024 at 13:00, 2 years ago Lumira Ventures Announces Promotion of Nikhil Thatte to Partner Lumira Ventures promotes Nikhil Thatte to Partner in recognition of his exceptional contributions to healthcare innovation. Nikhil's strategic insights drive firm's success and partnerships Life Sciences Healthcare Innovation Lumira Ventures Investment Firm Nikhil Thatte
BRIEF published on 04/02/2024 at 13:05, 2 years 3 months ago Lumira Ventures Invests in Nocion Therapeutics to Advance Chronic Cough Treatment Lumira Ventures Nocion Therapeutics Chronic Cough Treatment Phase 2b Study Series B Financing
BRIEF published on 04/02/2024 at 13:05, 2 years 3 months ago Lumira Ventures investit dans Nocion Therapeutics pour faire progresser le traitement de la toux chronique Lumira Ventures Financement De Série B Nocion Thérapeutique Traitement De La Toux Chronique Étude De Phase 2b
PRESS RELEASE published on 04/02/2024 at 13:00, 2 years 3 months ago Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment Lumira Ventures invests in Nocion Therapeutics' Taplucanium for Chronic Cough treatment. Series B funding of $70M secured from leading investors Series B Funding Lumira Ventures Nocion Therapeutics Taplucanium Chronic Cough
BRIEF published on 03/07/2024 at 13:05, 2 years 4 months ago Lumira Ventures Celebrates Team Promotions Ahead of International Women's Day Healthcare Innovation Gender Equality International Women's Day Lumira Ventures Team Promotions
Published on 07/22/2026 at 15:00, 8 hours 40 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 8 hours 40 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 9 hours 5 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 9 hours 10 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 22:20, 1 hour 19 minutes ago Quantinuum Appoints Chief Legal Officer and Chief People Officer
Published on 07/22/2026 at 21:01, 2 hours 38 minutes ago EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 20:44, 2 hours 55 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Published on 07/22/2026 at 20:08, 3 hours 31 minutes ago EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 18:19, 5 hours 21 minutes ago Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Published on 07/22/2026 at 18:19, 5 hours 21 minutes ago Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 5 hours 55 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:45, 5 hours 55 minutes ago Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
